Abstract
Total of 34 of Enterococcus include 15(44%) of Enterococcus faecium and 19 (56%) of Enterococcus faecalis, samples have been isolated during 2016-2017 from patients hospitalized in the National Institute for cardiovascular disease the samples have been taken from different clinical sources (Urine sample, Blood, Wound, Tracheal secretions and stool culture) the highest rate of isolates 15 (44%) from urine and least from stool and wound was 2(6%) meanwhile 7(12%) from tracheal secretion and 4(12%)from blood. The phenotypic analysis revealed the 4(12.5%) of the Enterococcus sp. This study aimed to compare the rate of infection with Enterococcus sp. between the hospitalized patient and detecting the Enterococcus faecalis and Enterococcus faecium by PCR (Polymerase chain reaction) amplification. Strains were vancomycin –resistant, 25% showed resistance to ampicillin, 12.5% to tetracycline, 91.7% to erythromycin, 87.5% to ciprofloxacin and 54.2% to rifampicin. The genotypic support of vancomycin resistance was represented by the vanA gene present in 20.6% of the E. faecium strains and 14.7% of E. faecalis.
First Page
37
Last Page
47
Recommended Citation
Muslem, Salaam Khudhur; Qasim, Othman Taha; Rasool, Sarah Rahman; and Al-Taee, Muataz Mohammed
(2021)
"Antibiotic resistance markers in Enterococcus sp. isolates,"
Al-Nisour Journal for Medical Sciences: Vol. 3:
Iss.
1, Article 4.
DOI: https://doi.org/10.70492/2664-0554.1057